Morning Movers 05/08: (IEC) (GNRC) (SVNT) (ARNA) Higher; (MRGE) (FOSL) (MAKO) (AVL) Lower
Tweet
Share
E-mail
Get Alerts MRGE Hot Sheet
Join SI Premium – FREE
Merge Healthcare, Inc. (NASDAQ: MRGE) 38.7% LOWER; reported Q1 EPS of $0.03, $0.01 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $61.6 million versus the consensus estimate of $64.83 million. The company withdrew its previous outlook. Also announced the creation of two operating groups to align more effectively to market trends.
Fossil, Inc. (NASDAQ: FOSL) 37% LOWER; reported Q1 EPS of $0.93, $0.01 better than the analyst estimate of $0.92. Revenue for the quarter came in at $589.5 million versus the consensus estimate of $617.64 million. Sees Q2 2012 EPS of $0.77-$0.79, versus the consensus of $0.94. Sees FY2012 EPS of $5.30-$5.40, versus prior guidance of $5.40-$5.50 and the consensus of $5.56.
MAKO Surgical Corp (NASDAQ: MAKO) 36.7% LOWER; reported Q1 EPS of ($0.28), $0.08 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $19.6 million versus the consensus estimate of $23.71 million. Based on the slower than expected start to the year, MAKO now anticipates selling 52 to 58 RIO systems in 2012, which compares to prior guidance of 56 to 62 RIO system sales. MAKOplasty procedure guidance remains unchanged at 11,000 to 13,000 expected procedures in 2012.
IEC Electronics Corp. (NYSE: IEC) 28.2% HIGHER; reported Q2 EPS of $0.26, $0.14 better than the analyst estimate of $0.12. Revenue for the quarter came in at $38.02 million versus the consensus estimate of $35.5 million.
Generac Holdings (NYSE: GNRC) 26.3% HIGHER; reported Q1 EPS of $0.96, $0.25 better than the analyst estimate of $0.71. Revenue for the quarter came in at $294.6 million versus the consensus estimate of $249.65 million.
Avalon Rare Metals (AMEX: AVL) 26.2% LOWER; offered an update on its Nechalacho Project. The company does not expect initial production until late 2016.
Synchronoss Technologies, Inc. (NASDAQ: SNCR) 23.7% LOWER; reported Q1 EPS of $0.26, $0.01 better than the analyst estimate of $0.25. Revenue for the quarter came in at $64.9 million versus the consensus estimate of $64.16 million.
Dendreon Corp (NASDAQ: DNDN) 21.1% LOWER; reported Q1 EPS of ($0.59), $0.04 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $82 million versus the consensus estimate of $80.97 million.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) 20.5% HIGHER; has entered into definitive agreements with certain holders of its currently outstanding 4.75% convertible senior notes due 2018. Pursuant to the terms of the definitive agreements, upon the closing of the transactions contemplated therein, which is expected to occur on May 9, 2012, subject to certain customary closing conditions, the Company will raise approximately $44 million in net proceeds and extend the maturity date of approximately 50% of the Existing Notes by approximately 15 months.
Arena Pharmaceuticals (Nasdaq: ARNA) 19.1% HIGHER; After originally trading down on FDA staff questions ahead of the May 10 FDA AdCom for weight loss drug Locaserin, Arena shares moved higher as the FDA released the briefing documents for the meeting.
Grand Canyon Education, Inc. (NASDAQ: LOPE) 16.8% HIGHER; reported Q1 EPS of $0.32, $0.06 better than the analyst estimate of $0.26. Revenue for the quarter came in at $117.1 million versus the consensus estimate of $113.41 million. Sees FY2012 EPS of $1.24-$1.30, versus the consensus of $1.21. Sees FY2012 revenue of $478-$486 million, versus the consensus of $477.5 million.
Furmanite (NYSE: FRM) 16.7% LOWER; reported Q1 EPS of ($0.02), $0.11 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $71.78 million versus the consensus estimate of $78.5 million.
Sun Healthcare Group, Inc. (NASDAQ: SUNH) 16.2% LOWER; reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $458.5 million versus the consensus estimate of $474.4 million.
Wesco Aircraft Holdings (NYSE: WAIR) 16.1% LOWER; reported Q2 EPS of $0.22, $0.04 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $182.1 million versus the consensus estimate of $191.8 million.
China Valves Technology, Inc. (NASDAQ: CVVT) 15.8% LOWER; reported Q2 EPS of $0.05, versus $0.21 reported last year. Revenue for the quarter came in at $38.4 million, versus $41.83 million reported last year. Reaffirmed FY2012 guidance.
Callon Petroleum (NYSE: CPE) 15.1% LOWER; reported Q1 EPS of 1 cent, vs. the consensus estimate of 6 cents. The stock was downgraded at Howard Weil earlier.
Scotts (NYSE: SMG) 14.8% LOWER; reported Q2 adj-EPS of $2.15, beats by 9c, on sales of $1.17 billion, vs. the consensus estimate of $1.2 billion. Reaffirms its FY12 EPS outlook.
Matrix Service Co (NASDAQ: MTRX) 14.7% LOWER; reported Q3 EPS of $0.19, $0.02 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $183.9 million versus the consensus estimate of $182.9 million. Sees FY2012 EPS of $0.77-$0.85, versus prior guidance of $0.85-$0.95 and the consensus of $0.90. Matrix Service Co sees FY2012 revenue of $725-$750 million, versus prior guidance of $675-$725 million and the consensus of $750.3 million.
GTx, Inc. (NASDAQ: GTXI) 14.2% HIGHER; reported Q1 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.83 million versus the consensus estimate of $2.32 million. Said the FDA removed its Full Clinical Hold on Investigational New Drug application for Capesaris following the review by the FDA of the complete response and its new Phase II clinical protocol.
Vitamin Shoppe (NYSE: VSI) 13.9% HIGHER; reported Q1 EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $248.1 million versus the consensus estimate of $239.71 million. Comps up 9.6%.
Kingold Jewelry (Nasdaq: KGJI) 13.8% HIGHER; shares continuing higher following a 23 percent run-up on Thursday of last week, then an 11 percent move over Friday and Monday's sessions. Shares were trading in a range over the last two weeks following a strong move over the $1.50 level.
Dun & Bradstreet Corp. (NYSE: DNB) 13.3% LOWER; reported Q1 EPS of $1.35, in-line with the analyst estimate of $1.35. Revenue for the quarter came in at $390.1 million versus the consensus estimate of $397.5 million.
Pros Holdings, Inc. (NYSE: PRO) 13.3% LOWER; reported Q1 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $27 million versus the consensus estimate of $26.9 million. Sees Q2 2012 EPS of $0.08-$0.09, versus the consensus of $0.10.
Rackspace Hosting (NYSE: RAX) 13.2% LOWER; reported Q1 EPS of $0.17, $0.01 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $301.4 million versus the consensus estimate of $300.27 million.
Complete Genomics, Inc. (NASDAQ: GNOM) 12.7% LOWER; reported Q1 EPS of ($0.60), $0.02 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $3.91 million versus the consensus estimate of $4.84 million.
Synacor (NASDAQ: SYNC) 11.8% LOWER; BofA/Merrill Lynch downgraded the stock from Buy to Underperform.
NetQin Mobile (NYSE: NQ) 11.7% LOWER; reported Q1 EPS of $0.04, $0.09 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $16 million versus the consensus estimate of $14.75 million. Sees Q212 revenue of $17.5-$17.8 million, versus the consensus of $16.60 million. Sees FY2012 revenue of $73-$75 million, versus the consensus of $71.90 million.
Clean Energy Fuels Corp. (NASDAQ: CLNE) 11.6% LOWER; reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $73.6 million versus the consensus estimate of $81.66 million.
OfficeMax, Inc. (NYSE: OMX) 11.1% HIGHER; reported Q1 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.86 billion. Sees Q2 sales flat to slightly lower. Sees FY12 sales flat to slightly higher.
Fossil, Inc. (NASDAQ: FOSL) 37% LOWER; reported Q1 EPS of $0.93, $0.01 better than the analyst estimate of $0.92. Revenue for the quarter came in at $589.5 million versus the consensus estimate of $617.64 million. Sees Q2 2012 EPS of $0.77-$0.79, versus the consensus of $0.94. Sees FY2012 EPS of $5.30-$5.40, versus prior guidance of $5.40-$5.50 and the consensus of $5.56.
MAKO Surgical Corp (NASDAQ: MAKO) 36.7% LOWER; reported Q1 EPS of ($0.28), $0.08 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $19.6 million versus the consensus estimate of $23.71 million. Based on the slower than expected start to the year, MAKO now anticipates selling 52 to 58 RIO systems in 2012, which compares to prior guidance of 56 to 62 RIO system sales. MAKOplasty procedure guidance remains unchanged at 11,000 to 13,000 expected procedures in 2012.
IEC Electronics Corp. (NYSE: IEC) 28.2% HIGHER; reported Q2 EPS of $0.26, $0.14 better than the analyst estimate of $0.12. Revenue for the quarter came in at $38.02 million versus the consensus estimate of $35.5 million.
Generac Holdings (NYSE: GNRC) 26.3% HIGHER; reported Q1 EPS of $0.96, $0.25 better than the analyst estimate of $0.71. Revenue for the quarter came in at $294.6 million versus the consensus estimate of $249.65 million.
Avalon Rare Metals (AMEX: AVL) 26.2% LOWER; offered an update on its Nechalacho Project. The company does not expect initial production until late 2016.
Synchronoss Technologies, Inc. (NASDAQ: SNCR) 23.7% LOWER; reported Q1 EPS of $0.26, $0.01 better than the analyst estimate of $0.25. Revenue for the quarter came in at $64.9 million versus the consensus estimate of $64.16 million.
Dendreon Corp (NASDAQ: DNDN) 21.1% LOWER; reported Q1 EPS of ($0.59), $0.04 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $82 million versus the consensus estimate of $80.97 million.
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) 20.5% HIGHER; has entered into definitive agreements with certain holders of its currently outstanding 4.75% convertible senior notes due 2018. Pursuant to the terms of the definitive agreements, upon the closing of the transactions contemplated therein, which is expected to occur on May 9, 2012, subject to certain customary closing conditions, the Company will raise approximately $44 million in net proceeds and extend the maturity date of approximately 50% of the Existing Notes by approximately 15 months.
Arena Pharmaceuticals (Nasdaq: ARNA) 19.1% HIGHER; After originally trading down on FDA staff questions ahead of the May 10 FDA AdCom for weight loss drug Locaserin, Arena shares moved higher as the FDA released the briefing documents for the meeting.
Grand Canyon Education, Inc. (NASDAQ: LOPE) 16.8% HIGHER; reported Q1 EPS of $0.32, $0.06 better than the analyst estimate of $0.26. Revenue for the quarter came in at $117.1 million versus the consensus estimate of $113.41 million. Sees FY2012 EPS of $1.24-$1.30, versus the consensus of $1.21. Sees FY2012 revenue of $478-$486 million, versus the consensus of $477.5 million.
Furmanite (NYSE: FRM) 16.7% LOWER; reported Q1 EPS of ($0.02), $0.11 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $71.78 million versus the consensus estimate of $78.5 million.
Sun Healthcare Group, Inc. (NASDAQ: SUNH) 16.2% LOWER; reported Q1 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $458.5 million versus the consensus estimate of $474.4 million.
Wesco Aircraft Holdings (NYSE: WAIR) 16.1% LOWER; reported Q2 EPS of $0.22, $0.04 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $182.1 million versus the consensus estimate of $191.8 million.
China Valves Technology, Inc. (NASDAQ: CVVT) 15.8% LOWER; reported Q2 EPS of $0.05, versus $0.21 reported last year. Revenue for the quarter came in at $38.4 million, versus $41.83 million reported last year. Reaffirmed FY2012 guidance.
Callon Petroleum (NYSE: CPE) 15.1% LOWER; reported Q1 EPS of 1 cent, vs. the consensus estimate of 6 cents. The stock was downgraded at Howard Weil earlier.
Scotts (NYSE: SMG) 14.8% LOWER; reported Q2 adj-EPS of $2.15, beats by 9c, on sales of $1.17 billion, vs. the consensus estimate of $1.2 billion. Reaffirms its FY12 EPS outlook.
Matrix Service Co (NASDAQ: MTRX) 14.7% LOWER; reported Q3 EPS of $0.19, $0.02 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $183.9 million versus the consensus estimate of $182.9 million. Sees FY2012 EPS of $0.77-$0.85, versus prior guidance of $0.85-$0.95 and the consensus of $0.90. Matrix Service Co sees FY2012 revenue of $725-$750 million, versus prior guidance of $675-$725 million and the consensus of $750.3 million.
GTx, Inc. (NASDAQ: GTXI) 14.2% HIGHER; reported Q1 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.83 million versus the consensus estimate of $2.32 million. Said the FDA removed its Full Clinical Hold on Investigational New Drug application for Capesaris following the review by the FDA of the complete response and its new Phase II clinical protocol.
Vitamin Shoppe (NYSE: VSI) 13.9% HIGHER; reported Q1 EPS of $0.61, $0.04 better than the analyst estimate of $0.57. Revenue for the quarter came in at $248.1 million versus the consensus estimate of $239.71 million. Comps up 9.6%.
Kingold Jewelry (Nasdaq: KGJI) 13.8% HIGHER; shares continuing higher following a 23 percent run-up on Thursday of last week, then an 11 percent move over Friday and Monday's sessions. Shares were trading in a range over the last two weeks following a strong move over the $1.50 level.
Dun & Bradstreet Corp. (NYSE: DNB) 13.3% LOWER; reported Q1 EPS of $1.35, in-line with the analyst estimate of $1.35. Revenue for the quarter came in at $390.1 million versus the consensus estimate of $397.5 million.
Pros Holdings, Inc. (NYSE: PRO) 13.3% LOWER; reported Q1 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $27 million versus the consensus estimate of $26.9 million. Sees Q2 2012 EPS of $0.08-$0.09, versus the consensus of $0.10.
Rackspace Hosting (NYSE: RAX) 13.2% LOWER; reported Q1 EPS of $0.17, $0.01 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $301.4 million versus the consensus estimate of $300.27 million.
Complete Genomics, Inc. (NASDAQ: GNOM) 12.7% LOWER; reported Q1 EPS of ($0.60), $0.02 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $3.91 million versus the consensus estimate of $4.84 million.
Synacor (NASDAQ: SYNC) 11.8% LOWER; BofA/Merrill Lynch downgraded the stock from Buy to Underperform.
NetQin Mobile (NYSE: NQ) 11.7% LOWER; reported Q1 EPS of $0.04, $0.09 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $16 million versus the consensus estimate of $14.75 million. Sees Q212 revenue of $17.5-$17.8 million, versus the consensus of $16.60 million. Sees FY2012 revenue of $73-$75 million, versus the consensus of $71.90 million.
Clean Energy Fuels Corp. (NASDAQ: CLNE) 11.6% LOWER; reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $73.6 million versus the consensus estimate of $81.66 million.
OfficeMax, Inc. (NYSE: OMX) 11.1% HIGHER; reported Q1 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $1.87 billion versus the consensus estimate of $1.86 billion. Sees Q2 sales flat to slightly lower. Sees FY12 sales flat to slightly higher.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Mobility Global (MBGL) at Neutral
- BofA truck shipper survey shows demand outlook rises modestly
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
